BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33272297)

  • 1. Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency.
    Lu D; Han F; Qiu W; Zhang H; Ye J; Liang L; Wang Y; Ji W; Zhan X; Gu X; Han L
    Orphanet J Rare Dis; 2020 Dec; 15(1):340. PubMed ID: 33272297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and mutation analysis of 24 Chinese patients with ornithine transcarbamylase deficiency.
    Shao Y; Jiang M; Lin Y; Mei H; Zhang W; Cai Y; Su X; Hu H; Li X; Liu L
    Clin Genet; 2017 Sep; 92(3):318-322. PubMed ID: 28266016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency].
    Sun WH; Yang Y; Zhang YP; Li XT; Zhang M; Cao Y; Wang Y
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):356-60. PubMed ID: 21624287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
    Choi JH; Lee BH; Kim JH; Kim GH; Kim YM; Cho J; Cheon CK; Ko JM; Lee JH; Yoo HW
    J Hum Genet; 2015 Sep; 60(9):501-7. PubMed ID: 25994866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple screening method for heterozygous female patients with ornithine transcarbamylase deficiency.
    Iijima H; Kubota M
    Mol Genet Metab; 2022 Nov; 137(3):301-307. PubMed ID: 36252454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients.
    Zhou Q; Huang H; Ma L; Zhu T
    Biomed Res Int; 2020; 2020():5690915. PubMed ID: 32934962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
    Sugahara G; Yamasaki C; Yanagi A; Furukawa S; Ogawa Y; Fukuda A; Enosawa S; Umezawa A; Ishida Y; Tateno C
    J Inherit Metab Dis; 2021 May; 44(3):618-628. PubMed ID: 33336822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.
    Lee JH; Kim GH; Yoo HW; Cheon CK
    Pediatr Neurol; 2014 Sep; 51(3):354-359.e1. PubMed ID: 25011434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
    Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
    Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention for late-onset ornithine transcarbamylase deficiency.
    Fujisawa D; Mitsubuchi H; Matsumoto S; Iwai M; Nakamura K; Hoshide R; Harada N; Yoshino M; Endo F
    Pediatr Int; 2015; 57(1):e1-3. PubMed ID: 25711267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.
    Arranz JA; Riudor E; Marco-Marín C; Rubio V
    J Inherit Metab Dis; 2007 Apr; 30(2):217-26. PubMed ID: 17334707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluations revealed pre-symptomatic citrulline concentrations measured by newborn screening were significantly low in late-onset ornithine transcarbamylase deficiency patients.
    Lee T; Yoshii K; Yoshida S; Suga T; Nakamura K; Sasai H; Murayama K; Kobayashi H; Hasegawa Y; Takeshima Y
    Clin Chim Acta; 2020 Nov; 510():633-637. PubMed ID: 32828733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].
    Division of Genetics and Metabolism, Child Diseases and Health Care Branch, Chinese Association for Maternal and Child Health
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):539-547. PubMed ID: 33210478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.
    Tarasenko TN; Rosas OR; Singh LN; Kristaponis K; Vernon H; McGuire PJ
    PLoS One; 2015; 10(2):e0116594. PubMed ID: 25647322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of orotic acid measurement in routine newborn screening for urea cycle disorders.
    Staretz-Chacham O; Daas S; Ulanovsky I; Blau A; Rostami N; Saraf-Levy T; Abu Salah N; Anikster Y; Banne E; Dar D; Dumin E; Fattal-Valevski A; Falik-Zaccai T; Hershkovitz E; Josefsberg S; Khammash H; Keidar R; Korman SH; Landau Y; Lerman-Sagie T; Mandel D; Mandel H; Marom R; Morag I; Nadir E; Yosha-Orpaz N; Pode-Shakked B; Pras E; Reznik-Wolf H; Saada A; Segel R; Shaag A; Shaul Lotan N; Spiegel R; Tal G; Vaisid T; Zeharia A; Almashanu S
    J Inherit Metab Dis; 2021 May; 44(3):606-617. PubMed ID: 33190319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency.
    Peng MZ; Li XZ; Mei HF; Sheng HY; Yin X; Jiang MY; Cai YN; Su L; Lin YT; Shao YX; Liu L
    Clin Biochem; 2020 Oct; 84():63-72. PubMed ID: 32569589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of clinical features, metabolic profiling and gene mutations of patients with ornithine transcarbamylase deficiency].
    Wang Y; Liu X; Wu H; Liu H; Wang C; He X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):148-51. PubMed ID: 24711021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
    Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.